Self-reports of executive dysfunction in current ecstasy/polydrug Users
- PMID: 22960437
- DOI: 10.1097/WNN.0b013e318261459c
Self-reports of executive dysfunction in current ecstasy/polydrug Users
Abstract
Objectives/background: Ecstasy/polydrug users have exhibited deficits in executive functioning in laboratory tests. We sought to extend these findings by investigating the extent to which ecstasy/polydrug users manifest executive deficits in everyday life.
Methods: Forty-two current ecstasy/polydrug users, 18 previous (abstinent for at least 6 months) ecstasy/polydrug users, and 50 non-users of ecstasy (including both non-users of any illicit drug and some cannabis-only users) completed the self-report Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) measure.
Results: Current ecstasy/polydrug users performed significantly worse than previous users and non-users on subscales measuring inhibition, self-monitoring, initiating action, working memory, planning, monitoring ongoing task performance, and organizational ability. Previous ecstasy/polydrug users did not differ significantly from non-users. In regression analyses, although the current frequency of ecstasy use accounted for statistically significant unique variance on 3 of the 9 BRIEF-A subscales, daily cigarette consumption was the main predictor in 6 of the subscales.
Conclusions: Current ecstasy/polydrug users report more executive dysfunction than do previous users and non-users. This finding appears to relate to some aspect of ongoing ecstasy use and seems largely unrelated to the use of other illicit drugs. An unexpected finding was the association of current nicotine consumption with executive dysfunction.
Similar articles
-
Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.Exp Clin Psychopharmacol. 2013 Dec;21(6):507-15. doi: 10.1037/a0034002. Epub 2013 Sep 30. Exp Clin Psychopharmacol. 2013. PMID: 24080019 Clinical Trial.
-
Everyday and prospective memory deficits in ecstasy/polydrug users.J Psychopharmacol. 2011 Apr;25(4):453-64. doi: 10.1177/0269881109359101. Epub 2010 Feb 1. J Psychopharmacol. 2011. PMID: 20123936
-
Everyday memory deficits in ecstasy-polydrug users.J Psychopharmacol. 2007 Sep;21(7):709-17. doi: 10.1177/0269881107077220. Epub 2007 Jul 2. J Psychopharmacol. 2007. PMID: 17606476
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.J Psychopharmacol. 2006 Mar;20(2):147-63. doi: 10.1177/0269881106063268. J Psychopharmacol. 2006. PMID: 16510474 Review.
Cited by
-
Executive function at baseline and follow-up in opioid maintenance patients and its relation to psychiatric comorbidity and substance use patterns.BMC Psychiatry. 2025 Apr 17;25(1):396. doi: 10.1186/s12888-025-06524-w. BMC Psychiatry. 2025. PMID: 40247226 Free PMC article.
-
Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).Psychopharmacology (Berl). 2011 Jun;215(4):761-74. doi: 10.1007/s00213-011-2174-y. Epub 2011 Feb 8. Psychopharmacology (Berl). 2011. PMID: 21301817
-
Adolescent Executive Dysfunction in Daily Life: Relationships to Risks, Brain Structure and Substance Use.Front Behav Neurosci. 2017 Nov 13;11:223. doi: 10.3389/fnbeh.2017.00223. eCollection 2017. Front Behav Neurosci. 2017. PMID: 29180956 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical